First Report of Cerebral Venous Thrombosis Following Inactivated-Virus Covid Vaccination (Sinopharm and Sinovac).
J Stroke Cerebrovasc Dis
; 31(3): 106298, 2022 Mar.
Article
in English
| MEDLINE | ID: covidwho-1627029
ABSTRACT
Cerebral venous thrombosis (CVT) is an uncommon cerebrovascular disease, which has been reported with covid infection as well as covid vaccines, particularly AstraZeneca and Janssen vaccines. We present four consecutive cases of CVT after receiving either Sinopharm or Sinovac vaccine, both of which are composed of an inactivated-virus. All the patients recovered well with anticoagulation and discharged with a good functional outcome. This is the first case series reporting CVT following the administration of these vaccines.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Intracranial Thrombosis
/
COVID-19 Vaccines
Type of study:
Case report
/
Prognostic study
Topics:
Vaccines
Limits:
Humans
Language:
English
Journal:
J Stroke Cerebrovasc Dis
Journal subject:
Vascular Diseases
/
Brain
Year:
2022
Document Type:
Article
Affiliation country:
J.jstrokecerebrovasdis.2021.106298
Similar
MEDLINE
...
LILACS
LIS